Rare eye diseases are the leading cause of untreatable blindness in Europe and affect people of all ages. The RESTORE VISION ...
Hosted on MSN5d
"Don't rub your eyes", these are the damages left on the cornea by this compulsive gestureKeratoconus is a rare disease that arises in childhood and is characterized by compulsive eye rubbing and changing ...
Advancements in dry eye care focus on improvements seen in patients treated with cyclosporine 0.09% following inadequate ...
Corneal Ulcer Treatment MarketThe global corneal ulcer treatment market is projected to grow at a CAGR of 5.2% from 2024 to 2034, reaching a market value of USD 1,601.1 million by 2034. In 2024, the ...
Combining eyelid pressure patching with AMT effectively heals persistent corneal epithelial defects, offering rapid ...
A PDUFA date has been set for October 20, 2025. If approved, Epoxia will be the first epi-on corneal crosslinking on the ...
Biocompatible nanoadhesive enhances corneal transplants, minimizing inflammation and infection risks
Because the cornea is an avascular, low-cell-density tissue that relies on aqueous humor circulation to maintain metabolism, ...
Glaukos (GKOS) announced it has received the “Day 74” notification from the U.S. Food and Drug Administration FDA acknowledging the previously ...
After receiving the Day 74 letter, which outlines the FDA’s initial assessment of the application, the agency accepted Epioxa ...
Glaukos' Epioxa NDA for keratoconus is under FDA review, with a decision expected by October 2025. Phase 3 trials support its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback